Elhadj Djeriou

A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study

James McCarthy, Thomas Rückle, Elhadj Djeriou et al. · Malaria Journal · 2016 · 127 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study

Jana Held, Christian Supan, Carmen L. Ospina Salazar et al. · The Lancet Infectious Diseases · 2015 · 90 citations

Pharmacy, Infectious Diseases, Pharmacology +12

A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria

Adoke Yeka, Rella Zoleko‐Manego, Serge Ouoba et al. · Malaria Journal · 2021 · 59 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Liver Enzyme Elevations in Plasmodium falciparum Volunteer Infection Studies: Findings and Recommendations

Mohamed Farouk Chughlay, Samantha Akakpo, Anand Odedra et al. · American Journal of Tropical Medicine and Hygiene · 2020 · 33 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +16

Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria

Christian Supan, Ghyslain Mombo‐Ngoma, Maryvonne Kombila et al. · American Journal of Tropical Medicine and Hygiene · 2017 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13